Late-Stage Funding Dominance and Global Market Dynamics
Key Questions
What is Roche's acquisition of PathAI?
Roche acquired PathAI for $750 million upfront (up to $1.05 billion total) to advance AI-powered digital pathology and precision oncology. It extends their 2021 partnership.
What other AI biotech deals occurred?
Anthropic invested $400 million in Coefficient Bio, signaling big pharma's acceleration in AI diagnostics and healthtech integration.
Why is big pharma pursuing AI health acquisitions?
Acquisitions like Roche-PathAI and Anthropic-Coefficient Bio reflect pharma's push to integrate AI for diagnostics, pathology, and precision medicine advancements.
K-shaped market: 91% of US VC in $100M+ rounds, AI captures 86% US VC. European AI surge (UK funding up 102%, Mistral, SoftBank €75B). China IPO pressure (DeepSeek $70.8B target). Fintech M&A (Bloomberg-Canoe, Legora-Wexler). Global M&A Q2 $324B disclosed. Corporate VC via VCaaS model.